7th September 2024

Breast Cancer 2024 Symposium

Prevention, Early Detection, and Management

We are honoured to have you join us for this paramount event, organised and sponsored by EuroNoxx Medical Group Ltd., in collaboration with the London International Medical School (LIMS) and our esteemed partner, Koning Corporation from the United States of America (USA). This innovative and ambitious programme convenes leading experts from right here in the United Kingdom (UK) and sponsored speakers from the USA to provide comprehensive insights into breast cancer prevention, early detection, and management. We are resolute in our commitment to ensuring the highest standards of quality and integrity in medical devices and healthcare supplies. We trust that this symposium will not only educate and inspire but also foster new collaborations and innovations in the battle against breast cancer. We appreciate your participation in this critical event.

Sincerely,

Dr. Mandeep Goma MD (Anesthesia & Critical Care) Founder and Managing Director Euronoxx Medical Group Ltd.

Prof. Sam Lingam MD (Hons.), FRCPCH, FRCP, DCH, DRCOG Scientific Advisor, EuroNoxx Medical Group Ltd. Dean, London International Medical School (LIMS)

Audience: SPONSORS, GENERAL ATTENDIES, AND CANCER VICTIMS

Registration Fees: £35, £50, £5.

Location: Royal Society of Medicine, 1 Wimpole Street, London, W1G 0AE

Contact: Edward Beasley Symposium Secretary

+44 74 2111 6282
edward@euronoxxmedical.com